Chicago Equity Partners LLC increased its holdings in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 6.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,050 shares of the company’s stock after acquiring an additional 900 shares during the quarter. Chicago Equity Partners LLC’s holdings in Tabula Rasa HealthCare were worth $1,222,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of TRHC. Wells Fargo & Company MN raised its position in shares of Tabula Rasa HealthCare by 10.2% during the 1st quarter. Wells Fargo & Company MN now owns 17,743 shares of the company’s stock worth $689,000 after purchasing an additional 1,643 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in shares of Tabula Rasa HealthCare during the 1st quarter worth about $672,000. UBS Group AG raised its position in shares of Tabula Rasa HealthCare by 1,403.7% during the 1st quarter. UBS Group AG now owns 32,676 shares of the company’s stock worth $1,268,000 after purchasing an additional 30,503 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Tabula Rasa HealthCare by 18.5% during the 1st quarter. The Manufacturers Life Insurance Company now owns 9,297 shares of the company’s stock worth $360,000 after purchasing an additional 1,453 shares during the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Tabula Rasa HealthCare by 21.9% during the 1st quarter. California State Teachers Retirement System now owns 18,545 shares of the company’s stock worth $720,000 after purchasing an additional 3,330 shares during the last quarter. 75.36% of the stock is currently owned by institutional investors and hedge funds.

In other news, President Orsula V. Knowlton sold 8,000 shares of the stock in a transaction that occurred on Friday, August 17th. The shares were sold at an average price of $72.23, for a total value of $577,840.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last three months, insiders sold 48,000 shares of company stock valued at $3,722,960. Corporate insiders own 14.00% of the company’s stock.

Tabula Rasa HealthCare stock opened at $64.76 on Wednesday. Tabula Rasa HealthCare Inc has a 1-year low of $27.25 and a 1-year high of $91.16. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.49 and a quick ratio of 0.46. The company has a market capitalization of $1.49 billion, a PE ratio of -1,619.00, a PEG ratio of 6.89 and a beta of 2.58.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The business had revenue of $54.42 million during the quarter, compared to analysts’ expectations of $52.87 million. During the same quarter in the prior year, the company posted $0.08 EPS. The business’s revenue for the quarter was up 66.3% on a year-over-year basis. As a group, equities analysts forecast that Tabula Rasa HealthCare Inc will post 0.42 earnings per share for the current fiscal year.

Several research analysts recently weighed in on the stock. Citigroup upped their price target on shares of Tabula Rasa HealthCare from $57.00 to $76.00 and gave the stock a “buy” rating in a research report on Thursday, August 9th. Piper Jaffray Companies upped their price objective on shares of Tabula Rasa HealthCare to $71.00 and gave the company an “overweight” rating in a research note on Wednesday, August 8th. Stifel Nicolaus started coverage on shares of Tabula Rasa HealthCare in a research note on Tuesday, September 11th. They set a “hold” rating and a $95.00 price objective for the company. Cantor Fitzgerald started coverage on shares of Tabula Rasa HealthCare in a research note on Thursday, September 6th. They set an “overweight” rating and a $99.00 price objective for the company. Finally, Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $81.60.

TRADEMARK VIOLATION NOTICE: “Tabula Rasa HealthCare Inc (TRHC) Position Lifted by Chicago Equity Partners LLC” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2018/11/14/tabula-rasa-healthcare-inc-trhc-position-lifted-by-chicago-equity-partners-llc.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Featured Story: Initial Public Offering (IPO)

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.